Weight Loss
Obesity Management Update 2023
As a nutrition support pharmacist, you can help obese patients manage obesity as New Year’s resolutions kick in. Continue to emphasize lifestyle changes, and review medication lists for possible causes of weight gain (antipsychotics, steroids, etc). Updated Canadian guidelines recommend considering medications for patients with …
Read more
Weight Loss
Rybelsus may be prescribed for weight loss
As a nutritional support pharmacist, you will hear about using Rybelsus (semaglutide) for weight loss , it is now available in Egypt . Rybelsus will be the first ORAL GLP-1 agonist for type 2 diabetes, it's a tablet version of injectable Ozempic . Glucagon-like peptide-1 (GLP-1) is inactivated in the…
Read more
Weight Loss
Explaining the role of Mounjaro for Type 2 Diabetes
As a pharmacy doctor, you will hear buzz about new injectable Mounjaro (tirzepatide), the first "twincretin" for type 2 diabetes . Think of Mounjaro as similar to a glucagon-like peptide-1 (GLP-1) agonist, BUT it’s also a glucose-dependent insulinotropic polypeptide (GIP) agonist. More twincretins are in the works. GL…
Read more
Weight Loss
Insulin resistance is a BIG problem
Metabolic syndrome is a BIG problem and growing. It affects over 25% of adults and 4% of adolescents. It's also called "insulin resistance syndrome" or "syndrome X" or "dysmetabolic syndrome" and even has its own ICD-9 code (see table 1) . New treatment guidelines will focus even more attention on it... …
Read more
Weight Loss
Reduce insulin if SAXENDA is used for weight loss
As a nutrition support pharmacist, you will hear more about using Saxenda for weight loss in adolescents 12 and up, not just in adults. Saxenda will be the first GLP-1 agonist for obesity, that in addition to stimulating insulin release and inhibiting glucagon secretion, slows gastric emptying and increases satiety after eating, (see our Note about Saxenda for weigh…
Read more
Social Plugin